Acclinate's system and method of using intelligent AI-based automated determination of clinical trial participation is now patent approved

Did you know that Acclinate's system and method of using intelligent AI-based automated determination of clinical trial participation is now patent approved?

Our innovative platform allows pharma to source diverse leads likely to participate in your clinical trial using predictive analytics and machine learning. 

Learn more about our system and process here →

https://cloud.google.com/blog/topics/startups/acclinate-advances-equity-and-diversity-in-clinical-trials